All News

Patients with blood cancer who underwent stem cell transplant and developed chronic graft-versus-host disease have more treatment options than ever before. But the formula for planning older and newer therapies has not yet been established.

A 13-time cancer survivor shares his complex, long and frustrating cancer journey, and explains how he is able to keep hope alive.

A colleague describes a fellow oncology nurse who welcomes everyone who walks through their doors and makes every effort to make patients feel as comfortable as possible.

The novel drug N-803 boosted response to Bacille Calmette-Guérin therapy in patients with non-muscle invasive bladder cancer, a study showed.

During anxious times throughout treatment, one patient details how her oncology nurse helped her to relax at visits to her cancer center.

Despite a testicular cancer diagnosis, men have options when it comes to starting or growing their family.

A melanoma survivor and former caregiver analyzes the way society’s labels shape our behaviors and identities.

Clinical trials that are designed to ask patients with bladder, kidney and prostate cancer about their smoking status may help patients better understand what to expect from their treatment based on their smoking habits.

From Jeff Bridges achieving remission from cancer to a cancer survivor who became a runway model, here’s what’s happening in the cancer landscape this week.

After determining an aggressive or non-aggressive treatment approach to mantle cell lymphoma, patients and clinicians must then discuss COVID-19 vaccine efficacy when determining a maintenance treatment strategy.

The eligible age of 65 years for Medicare may be discouraging patients from getting screenings and tests as they wait for more health coverage.

A cancer survivor explains that similar to combat veterans who experience post-traumatic stress after war, cancer survivors live with the impacts of their journey even after being in remission.

Cancer survivors who identify as lesbian, gay or bisexual report experiencing significantly more challenges in their survivorship than their heterosexual peers, according to recent study results.

A first-of-its-kind trial underway in patients with penile cancer may lead to a more effective therapy sequence, potentially avoiding unnecessary surgery.

Through the emotions and anxiety of cancer, she realized she was not living her life to the fullest, and that it isn't over yet.

The FDA’s approval of Exkivity marks the first approved oral therapy for this subgroup of patients with non-small cell lung cancer.

Tecartus was the first CAR-T cell therapy to be approved for the treatment of recurrent mantle cell lymphoma. Now, more than a year after its approval, a doctor discusses his experience prescribing the drug.

Although immunotherapy has provided patients with small cell lung cancer with a “light at the end of the tunnel,” an expert from City of Hope argues more research is needed.

A cancer survivor describes how survivors can help face their fears by connecting with each other.

Monitoring, rather than immediately treating, patients with low-risk prostate cancer may be a better approach, says an expert from UCSF Helen Diller Family Comprehensive Cancer Center.

Patients with relapsed/refractory, pretreated marginal zone lymphoma are now eligible for treatment with Brukinsa.

An expert explains the treatment options and personal life impacts of an essential thrombocythemia diagnosis.

GC4419 plus radiation improved progression-free survival and time to distant metastases in patients with unresectable or borderline resectable locally advanced pancreatic cancer.

Norm Macdonald, known for his work on “Saturday Night Live,” has died from cancer that was kept private for nine years.

Residing in neighborhoods that are within walking distance of destinations such as shops, restaurants and bus stops was associated with a decrease in BMI among black cancer survivors.

A woman with metastatic breast cancer describes a fulfilling experience of meeting another survivor who has lived a similar cancer journey, and the unique lasting connection it can create.

The overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.

One oncology nurse helped a patient with esophageal cancer throughout treatment by keeping her comfortable and maintaining her dignity.

In this episode of the “Cure Talks Cancer” Podcast, Dr. Spira a medical oncologist of the Virginia Cancer Specialists’ (VCS) discusses why KRASG12C is a prolific problem.

Immunotherapy and tyrosine kinase inhibitors may potentially change the treatment paradigm for patients with renal cell carcinoma, the most common type of kidney cancer in adults.